Bath & Body Works, Inc. $BBWI Holdings Raised by South Dakota Investment Council

South Dakota Investment Council increased its stake in Bath & Body Works, Inc. (NYSE:BBWI) by 65.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 798,796 shares of the company’s stock after purchasing an additional 314,614 shares during the quarter. South Dakota Investment Council owned about 0.39% of Bath & Body Works worth $20,577,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. First Horizon Corp acquired a new stake in shares of Bath & Body Works in the 3rd quarter worth approximately $29,000. Geneos Wealth Management Inc. increased its stake in shares of Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after acquiring an additional 801 shares during the period. Carolina Wealth Advisors LLC bought a new stake in Bath & Body Works during the third quarter worth approximately $54,000. Parkside Financial Bank & Trust lifted its position in Bath & Body Works by 24.6% in the second quarter. Parkside Financial Bank & Trust now owns 1,842 shares of the company’s stock worth $55,000 after purchasing an additional 364 shares during the period. Finally, Westfuller Advisors LLC bought a new position in Bath & Body Works during the 3rd quarter valued at $56,000. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works News Roundup

Here are the key news stories impacting Bath & Body Works this week:

• Positive Sentiment: Spring product collaboration (PEEPS) is drawing shopper interest, a potential boost to seasonal sales and merchandising momentum. PEEPS Collaboration / Valuation Check
• Positive Sentiment: Two small analyst actions raised targets: Barclays lifted its target to $21 (equal-weight) and another outlet reported a $23 target — incremental support but not strong bullish conviction. Barclays Price Target Note Price Target Raised to $23
• Neutral Sentiment: Investors are awaiting upcoming earnings and guidance; previews note key metrics to watch (same-store sales, margin trends, and inventory) that will drive near-term sentiment. Earnings uncertainty can amplify moves from other headlines. Earnings Preview
• Negative Sentiment: A wave of securities‑class‑action filings and multiple law‑firm notices seek lead plaintiffs for alleged misstatements covering June 2024–Nov 2025—heightening legal risk and potential future liabilities and distracting management. (Representative notices shown.) Robbins LLP Notice Levi & Korsinsky Filing
• Negative Sentiment: A sizeable institutional stake (~$129M) was liquidated as the firm cut its outlook, signaling reduced institutional conviction and adding selling pressure into the quarter. Stake Liquidation Report

Bath & Body Works Trading Down 3.3%

Shares of BBWI opened at $22.02 on Tuesday. The business’s 50-day moving average price is $22.19 and its 200 day moving average price is $23.63. The stock has a market capitalization of $4.51 billion, a P/E ratio of 6.78, a P/E/G ratio of 1.00 and a beta of 1.54. Bath & Body Works, Inc. has a 1-year low of $14.27 and a 1-year high of $36.89.

Bath & Body Works Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, March 6th. Stockholders of record on Friday, February 20th will be given a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 3.6%. The ex-dividend date of this dividend is Friday, February 20th. Bath & Body Works’s dividend payout ratio (DPR) is 24.62%.

Wall Street Analyst Weigh In

BBWI has been the topic of a number of research reports. Wells Fargo & Company dropped their price objective on Bath & Body Works from $33.00 to $25.00 and set an “overweight” rating on the stock in a research note on Friday, November 21st. Guggenheim assumed coverage on Bath & Body Works in a report on Tuesday, December 9th. They set a “neutral” rating on the stock. Barclays boosted their price target on shares of Bath & Body Works from $20.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Monday. Deutsche Bank Aktiengesellschaft began coverage on shares of Bath & Body Works in a research report on Thursday, January 8th. They set a “hold” rating and a $21.00 price objective for the company. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Bath & Body Works in a research note on Wednesday, January 21st. Three investment analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company’s stock. According to MarketBeat.com, Bath & Body Works presently has a consensus rating of “Hold” and an average target price of $23.79.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.